Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 359159, 8 pages
http://dx.doi.org/10.1155/2015/359159
Review Article

Irisin and Myonectin Regulation in the Insulin Resistant Muscle: Implications to Adipose Tissue: Muscle Crosstalk

1Laboratory of Physiology, Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal
2Department of Complementary Sciences, Coimbra Health School (ESTeSC), Instituto Politécnico de Coimbra, 3040 Coimbra, Portugal

Received 9 December 2014; Revised 7 April 2015; Accepted 13 April 2015

Academic Editor: Pedro M. Geraldes

Copyright © 2015 Luis Gamas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Negre-Salvayre, R. Salvayre, N. Augé, R. Pamplona, and M. Portero-Otín, “Hyperglycemia and glycation in diabetic complications,” Antioxidants and Redox Signaling, vol. 11, no. 12, pp. 3071–3109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Bugianesi, A. J. McCullough, and G. Marchesini, “Insulin resistance: a metabolic pathway to chronic liver disease,” Hepatology, vol. 42, no. 5, pp. 987–1000, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 37, supplement 1, pp. S81–S90, 2013. View at Publisher · View at Google Scholar
  4. M. Qatanani and M. A. Lazar, “Mechanisms of obesity-associated insulin resistance: many choices on the menu,” Genes and Development, vol. 21, no. 12, pp. 1443–1455, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Abdul-Ghani and R. A. Defronzo, “Pathogenesis of insulin resistance in skeletal muscle,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 476279, 19 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Chow, A. From, and E. Seaquist, “Skeletal muscle insulin resistance: the interplay of local lipid excess and mitochondrial dysfunction,” Metabolism: Clinical and Experimental, vol. 59, no. 1, pp. 70–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Dela and J. W. Helge, “Insulin resistance and mitochondrial function in skeletal muscle,” The International Journal of Biochemistry & Cell Biology, vol. 45, no. 1, pp. 11–15, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. K. E. Wellen and G. S. Hotamisligil, “Inflammation, stress, and diabetes,” The Journal of Clinical Investigation, vol. 115, no. 5, pp. 1111–1119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Guilherme, J. V. Virbasius, V. Puri, and M. P. Czech, “Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes,” Nature Reviews Molecular Cell Biology, vol. 9, no. 5, pp. 367–377, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Lefebvre, G. Chinetti, J.-C. Fruchart, and B. Staels, “Sorting out the roles of PPARα in energy metabolism and vascular homeostasis,” The Journal of Clinical Investigation, vol. 116, no. 3, pp. 571–580, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Moeschel, A. Beck, C. Weigert et al., “Protein kinase C-ζ-induced phosphorylation of Ser 318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1,” The Journal of Biological Chemistry, vol. 279, no. 24, pp. 25157–25163, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Boden, P. She, M. Mozzoli et al., “Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-κb pathway in rat liver,” Diabetes, vol. 54, no. 12, pp. 3458–3465, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Lionetti, M. P. Mollica, A. Lombardi, G. Cavaliere, G. Gifuni, and A. Barletta, “From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation,” Nutrition, Metabolism & Cardiovascular Diseases, vol. 19, no. 2, pp. 146–152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Eckardt, S. W. Görgens, S. Raschke, and J. Eckel, “Myokines in insulin resistance and type 2 diabetes,” Diabetologia, vol. 57, no. 6, pp. 1087–1099, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. B. K. Pedersen and M. A. Febbraio, “Muscles, exercise and obesity: skeletal muscle as a secretory organ,” Nature Reviwes, Endocrinology, vol. 8, no. 8, pp. 457–465, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M. M. Seldin, J. M. Peterson, M. S. Byerly, Z. Wei, and G. W. Wong, “Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis,” The Journal of Biological Chemistry, vol. 287, no. 15, pp. 11968–11980, 2012. View at Publisher · View at Google Scholar
  17. L. Pedersen and P. Hojman, “Muscle-to-organ cross talk mediated by myokines,” Adipocyte, vol. 1, no. 3, pp. 164–167, 2012. View at Publisher · View at Google Scholar
  18. B. K. Pedersen and C. Brandt, “The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 520258, 6 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Mathur and B. K. Pedersen, “Exercise as a mean to control low-grade systemic inflammation,” Mediators of Inflammation, vol. 2008, Article ID 109502, 6 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Orava, P. Nuutila, M. E. Lidell et al., “Different metabolic responses of human brown adipose tissue to activation by cold and insulin,” Cell Metabolism, vol. 14, no. 2, pp. 272–279, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. Cypess, S. Lehman, G. Williams et al., “Identification and importance of brown adipose tissue in adult humans,” The New England Journal of Medicine, vol. 360, no. 15, pp. 1509–1517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. W. D. van Marken Lichtenbelt, J. W. Vanhommerig, N. M. Smulders et al., “Cold-activated brown adipose tissue in healthy men,” The New England Journal of Medicine, vol. 360, no. 15, pp. 1500–1508, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. G. H. E. J. Vijgen, N. D. Bouvy, G. J. J. Teule, B. Brans, P. Schrauwen, and W. D. van Marken Lichtenbelt, “Brown adipose tissue in morbidly obese subjects,” PLoS ONE, vol. 6, no. 2, Article ID e17247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Wu, P. Boström, L. M. Sparks et al., “Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human,” Cell, vol. 150, no. 2, pp. 366–376, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Boström, J. Wu, M. P. Jedrychowski et al., “A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis,” Nature, vol. 481, no. 7382, pp. 463–468, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. I. Castillo-Quan, “From white to brown fat through the PGC-1α-dependent myokine irisin: implications for diabetes and obesity,” Disease Models and Mechanisms, vol. 5, no. 3, pp. 293–295, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Lee, J. D. Linderman, S. Smith et al., “Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans,” Cell Metabolism, vol. 19, no. 2, pp. 302–309, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Zhang, R. Li, Y. Meng et al., “Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling,” Diabetes, vol. 63, no. 2, pp. 514–525, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. P. J. Scarpace, S. Yenice, and N. Tümer, “Influence of exercise training and age on uncoupling protein mRNA expression in brown adipose tissue,” Pharmacology Biochemistry and Behavior, vol. 49, no. 4, pp. 1057–1059, 1994. View at Publisher · View at Google Scholar · View at Scopus
  30. R. De Matteis, F. Lucertini, M. Guescini et al., “Exercise as a new physiological stimulus for brown adipose tissue activity,” Nutrition, Metabolism & Cardiovascular Diseases, vol. 23, no. 6, pp. 582–590, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. C. D. Wrann, J. P. White, J. Salogiannnis et al., “Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway,” Cell Metabolism, vol. 18, no. 5, pp. 649–659, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. T. L. Rachid, A. Penna-de-Carvalho, I. Brighenti, M. B. Aguila, C. A. Mandarim-de-Lacerda, and V. Souza-Mello, “Fenofibrate (PPARalfa agonist) induces beige cell formation in subcutaneous white adipose tissue from diet-induced male obese mice,” Molecular and Cell Endocrinology, vol. 402, pp. 86–94, 2015. View at Google Scholar
  33. B. M. Spiegelman, “Banting lecture 2012: regulation of adipogenesis: toward new therapeutics for metabolic disease,” Diabetes, vol. 62, no. 6, pp. 1774–1782, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. X. Xu, Z. Ying, M. Cai et al., “Exercise ameliorates high-fat diet-induced metabolic and vascular dysfunction, and increases adipocyte progenitor cell population in brown adipose tissue,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 300, no. 5, pp. R1115–R1125, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Roca-Rivada, C. Castelao, L. L. Senin et al., “FNDC5/irisin is not only a myokine but also an adipokine,” PLoS ONE, vol. 8, no. 4, Article ID e60563, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Norheim, T. M. Langleite, M. Hjorth et al., “The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans,” The FEBS Journal, vol. 281, no. 3, pp. 739–749, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Kurdiova, M. Balaz, A. Mayer et al., “Exercise-mimicking treatment fails to increase Fndc5 mRNA & irisin secretion in primary human myotubes,” Peptides, vol. 56, pp. 1–7, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Besse-Patin, E. Montastier, C. Vinel et al., “Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine,” International Journal of Obesity, vol. 38, no. 5, pp. 707–713, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. J. A. Timmons, K. Baar, P. K. Davidsen, and P. J. Atherton, “Is irisin a human exercise gene?” Nature, vol. 488, no. 7413, pp. E9–E10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Raschke, M. Elsen, H. Gassenhuber et al., “Evidence against a beneficial effect of irisin in humans,” PLoS ONE, vol. 8, no. 9, Article ID e73680, 2013. View at Publisher · View at Google Scholar
  41. S. Pekkala, P. K. Wiklund, J. J. Hulmi et al., “Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health?” The Journal of Physiology, vol. 591, no. 21, pp. 5393–5400, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Kurdiova, M. Balaz, M. Vician et al., “Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies,” The Journal of Physiology, vol. 592, no. 5, pp. 1091–1107, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Aydin, T. Kuloglu, M. Yilmaz, M. Kalayci, I. Sahin, and D. Cicek, “Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45 min of a Turkish bath or running,” Peptides, vol. 50, pp. 13–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Hecksteden, M. Wegmann, A. Steffen et al., “Irisin and exercise training in humans—results from a randomized controlled training trial,” BMC Medicine, vol. 11, no. 1, article 235, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Brenmoeh, E. Albrecht, K. Komolka et al., “Irisin is elevated in skeletal muscle and serum of mice immediately after acute exercise,” International Journal of Biological Sciences, vol. 10, no. 3, pp. 338–349, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Y. Huh, G. Panagiotou, V. Mougios et al., “FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise,” Metabolism: Clinical and Experimental, vol. 61, no. 12, pp. 1725–1738, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Ellefsen, O. Vikmoen, G. Slettaløkken et al., “Irisin and FNDC5: effects of 12-week strength training, and relations to muscle phenotype and body mass composition in untrained women,” European Journal of Applied Physiology, vol. 114, no. 9, pp. 1875–1888, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Y. Huh, V. Mougios, A. Kabasakalis et al., “Exercise-induced irisin secretion is independent of age or fitness level and increased irisin may directly modulate muscle metabolism through AMPK activation,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 11, pp. E2154–E2161, 2014. View at Publisher · View at Google Scholar
  49. A. D. Anastasilakis, S. A. Polyzos, Z. G. Saridakis et al., “Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and association with gender, physical activity, diet, and body composition,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 9, pp. 3247–3255, 2014. View at Google Scholar
  50. D. Löffler, U. Müller, K. Scheuermann et al., “Serum irisin levels are regulated by acute strenuous exercise,” The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 4, pp. 1289–1299, 2015. View at Google Scholar
  51. Y. Tsuchiya, D. Ando, K. Goto, M. Kiushi, M. Yamakita, and K. Koyama, “High-intensity exercise causes greater irisin response compared with low-intensity exercise under similar energy consumption,” The Tohoku Journal of Experimental Medicine, vol. 233, no. 2, pp. 135–140, 2014. View at Google Scholar
  52. T. Hew-Butler, K. Landis-Piwowar, G. Byrd et al., “Plasma irisin in runners and non-runners: no favorable metabolic association in humans,” Physiological Reports, vol. 3, no. 1, Article ID e12262, 2015. View at Publisher · View at Google Scholar
  53. M. Elsen, S. Raschke, and J. Eckel, “Browning of white fat: does irisin play a role in humans?” The Journal of Endocrinology, vol. 222, no. 1, pp. 25–38, 2014. View at Google Scholar
  54. K. Højlund and P. Boström, “Irisin in obesity and type 2 diabetes,” Journal of Diabetes and Its Complications, vol. 27, no. 4, pp. 303–304, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. H. J. Lee, J. O. Lee, N. Kim et al., “Irisin, a novel myokine, regulates glucose uptake in skeletal muscle cells via AMPK,” Molecular Endocrinology, 2015. View at Publisher · View at Google Scholar
  56. R. A. Vaughan, N. P. Gannon, M. A. Barberena et al., “Characterization of the metabolic effects of irisin on skeletal muscle in vitro,” Diabetes, Obesity and Metabolism, vol. 16, no. 8, pp. 711–718, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. M. M. Seldin and G. W. Wong, “Regulation of tissue crosstalk by skeletal muscle-derived myonectin and other myokines,” Adipocyte, vol. 1, no. 4, pp. 200–202, 2012. View at Publisher · View at Google Scholar
  58. M. M. Seldin, X. Lei, S. Y. Tan, K. P. Stanson, Z. Wei, and G. W. Wong, “Skeletal muscle-derived myonectin activates the mammalian target of rapamycin (mTOR) pathway to suppress autophagy in liver,” The Journal of Biological Chemistry, vol. 288, no. 50, pp. 36073–36082, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. J. M. Moreno-Navarrete, F. Ortega, M. Serrano et al., “Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance,” The Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 4, pp. 769–778, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Zhang, P. Chen, S. Chen et al., “The association of new inflammatory markers with type 2 diabetes mellitus and macrovascular complications: a preliminary study,” European Review for Medical and Pharmacological Sciences, vol. 18, no. 11, pp. 1567–1572, 2014. View at Google Scholar
  61. C. Zhang, Z. Ding, G. Lv, J. Li, P. Zhou, and J. Zhang, “Lower irisin level in patients with type 2 diabetes mellitus: a case-control study and meta-analysis,” Journal of Diabetes, 2014. View at Publisher · View at Google Scholar
  62. R. Alis, F. Sanchis-Gomar, H. Pareja-Galeano et al., “Association between irisin and homocysteine in euglycemic and diabetic subjects,” Clinical Biochemistry, vol. 47, no. 18, pp. 333–335, 2014. View at Google Scholar
  63. J.-J. Liu, M. D. S. Wong, W. C. Toy et al., “Lower circulating irisin is associated with type 2 diabetes mellitus,” Journal of Diabetes and Its Complications, vol. 27, no. 4, pp. 365–369, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. Y.-K. Choi, M.-K. Kim, K. H. Bae et al., “Serum irisin levels in new-onset type 2 diabetes,” Diabetes Research and Clinical Practice, vol. 100, no. 1, pp. 96–101, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Xiang, G. Xiang, L. Yue, J. Zhang, and L. Zhao, “Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy,” Atherosclerosis, vol. 235, no. 2, pp. 328–333, 2014. View at Publisher · View at Google Scholar
  66. B. Yan, X. Shi, H. Zhang et al., “Association of serum irisin with metabolic syndrome in obese chinese adults,” PLoS ONE, vol. 9, no. 4, Article ID e94235, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Pardo, A. B. Crujeiras, M. Amil et al., “Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index,” International Journal of Endocrinology, vol. 2014, Article ID 857270, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Stengel, T. Hofmann, M. Goebel-Stengel, U. Elbelt, P. Kobelt, and B. F. Klapp, “Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity—correlation with body mass index,” Peptides, vol. 39, no. 1, pp. 125–130, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. A. B. Crujeiras, M. Pardo, A. Roca-Rivada et al., “Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women,” American Journal of Human Biology, vol. 26, no. 2, pp. 198–207, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. G. Panagiotou, L. Mu, B. Na, K. J. Mukamal, and C. S. Mantzoros, “Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk,” Metabolism, vol. 63, no. 10, pp. 1265–1271, 2014. View at Publisher · View at Google Scholar
  71. J. M. Peterson, R. Mart, and C. E. Bond, “Effect of obesity and exercise on the expression of the novel myokines, Myonectin and Fibronectin type III domain containing 5,” PeerJ, vol. 2, article e605, 2014. View at Publisher · View at Google Scholar
  72. A. Rodríguez, S. Becerril, L. Méndez-Giménez et al., “Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice,” International Journal of Obesity, vol. 39, no. 3, pp. 397–407, 2014. View at Publisher · View at Google Scholar
  73. N. Sharma, C. M. Castorena, and G. D. Cartee, “Greater insulin sensitivity in calorie restricted rats occurs with unaltered circulating levels of several important myokines and cytokines,” Nutrition & Metabolism, vol. 9, article 90, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Yang, D. Wei, C. Mo et al., “Saturated fatty acid palmitate-induced insulin resistance is accompanied with myotube loss and the impaired expression of health benefit myokine genes in C2C12 myotubes,” Lipids in Health and Disease, vol. 12, article 104, 2013. View at Publisher · View at Google Scholar · View at Scopus